• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肥胖糖尿病-严重联合免疫缺陷小鼠原位胰腺癌细胞移植瘤放射治疗的活体生物发光成像:一种新的针对和评估电离辐射疗效的方法。

In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation.

机构信息

Department of Surgery, University of Michigan, Ann Arbor, MI, USA.

出版信息

Transl Oncol. 2010 Jun 1;3(3):153-9. doi: 10.1593/tlo.09184.

DOI:10.1593/tlo.09184
PMID:20563256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2887644/
Abstract

Adenocarcinoma of the pancreas is a lethal malignancy, and better models to study tumor behavior in vivo are needed for the development ofmore effective therapeutics. Ionizing radiation is a treatment modality that is commonly used in the clinical setting, in particular, for locally confined disease; however, good model systems to study the effect of ionizing radiation in orthotopic tumors have not been established. In an attempt to create clinically relevant models for studying treatments directed against pancreatic cancer, we have defined a methodology to measure the effect of varying doses of radiation in established human pancreatic cancer orthotopic xenografts using two different pancreatic cancer cell lines (Panc-1 and BXPC3) infected with a lentiviral vector expressing CMV promoter-driven luciferase to allow bioluminescence imaging of live animals in real time. Quantifiable photon emission from luciferase signaling in vivo correlated well with actual tumor growth. Bioluminescence imaging of the established pancreatic xenografts was used to direct delivery of radiation to the orthotopic tumors and minimize off-target adverse effects. Growth delay was observed with schedules in the range of 7.5 Gy in five fractions to 10 Gy in four fractions, whereas doses 3 Gy or higher produced toxic adverse effects. In conclusion, we describe a model in which the effects of ionizing radiation, alone or in combination with other therapeutics, in orthotopic xenografts, can be studied.

摘要

胰腺腺癌是一种致命的恶性肿瘤,需要更好的体内肿瘤行为模型来开发更有效的治疗方法。电离辐射是一种在临床上常用的治疗方式,特别是对于局部局限性疾病;然而,尚未建立用于研究电离辐射对原位肿瘤影响的良好模型系统。为了创建用于研究针对胰腺癌的治疗方法的临床相关模型,我们定义了一种方法,使用两种不同的胰腺癌细胞系(Panc-1 和 BXPC3)感染表达 CMV 启动子驱动的荧光素酶的慢病毒载体,来测量不同剂量的辐射对已建立的人胰腺腺癌原位异种移植物的影响,从而实时对活体动物进行生物发光成像。来自活体荧光素酶信号的可量化光子发射与实际肿瘤生长很好地相关。已建立的胰腺异种移植的生物发光成像用于引导对原位肿瘤的放射治疗,并最大限度地减少脱靶不良反应。观察到与 7.5 Gy 分 5 次和 10 Gy 分 4 次的方案范围相关的生长延迟,而 3 Gy 或更高的剂量则会产生毒性不良反应。总之,我们描述了一种模型,其中可以研究单独或与其他治疗方法联合使用电离辐射对原位异种移植物的影响。

相似文献

1
In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation.非肥胖糖尿病-严重联合免疫缺陷小鼠原位胰腺癌细胞移植瘤放射治疗的活体生物发光成像:一种新的针对和评估电离辐射疗效的方法。
Transl Oncol. 2010 Jun 1;3(3):153-9. doi: 10.1593/tlo.09184.
2
Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts.新型临床前胰腺癌研究模型的建立:生物发光成像引导的局部照射和原位移植瘤的肿瘤监测。
Transl Oncol. 2012 Apr;5(2):77-84. doi: 10.1593/tlo.11316. Epub 2012 Apr 1.
3
Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.血管内皮生长因子可增强内皮细胞的存活能力及肿瘤的放射抗性。
Cancer J. 2002 Jan-Feb;8(1):47-54. doi: 10.1097/00130404-200201000-00009.
4
Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.卡培他滨和塞来昔布对接受照射和铅屏蔽的对侧人BxPC-3胰腺癌异种移植瘤的抗肿瘤疗效:远隔效应的临床意义
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8773-81. doi: 10.1158/1078-0432.CCR-05-0627.
5
In vivo bioluminescence imaging using orthotopic xenografts towards patient's derived-xenograft Medulloblastoma models.使用原位异种移植对患者来源的异种移植髓母细胞瘤模型进行体内生物发光成像。
Q J Nucl Med Mol Imaging. 2017 Mar;61(1):95-101. doi: 10.23736/S1824-4785.16.02959-9. Epub 2016 Dec 16.
6
Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.用于胰腺癌成像的放射性碘化苯丙氨酸衍生物:在人胰腺癌异种移植模型和炎症模型中与[18F]氟-2-脱氧-D-葡萄糖的比较研究。
Nucl Med Biol. 2005 Feb;32(2):137-45. doi: 10.1016/j.nucmedbio.2004.09.005.
7
MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.使用(64)Cu-NOTA-帕尼单抗F(ab')2片段对皮下或原位植入NOD-scid小鼠的患者源性胰腺癌异种移植瘤进行MicroPET/CT成像。
Nucl Med Biol. 2015 Feb;42(2):71-7. doi: 10.1016/j.nucmedbio.2014.10.009. Epub 2014 Oct 22.
8
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.胰腺癌的预靶向免疫正电子发射断层显像:克服循环抗原和内化抗体以降低辐射剂量
J Nucl Med. 2016 Mar;57(3):453-9. doi: 10.2967/jnumed.115.163824. Epub 2015 Oct 15.
9
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.源自细胞系和原发性肿瘤且具有不同转移活性的胰腺腺癌原位移植模型。
Pancreas. 2004 Oct;29(3):193-203. doi: 10.1097/00006676-200410000-00004.
10
Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.Numb/Notch信号通路调节增强人胰腺癌细胞的放射敏感性。
Tumour Biol. 2016 Nov;37(11):15145-15155. doi: 10.1007/s13277-016-5311-8. Epub 2016 Sep 27.

引用本文的文献

1
Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide (D O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma.通过使用水的氘代物重水(D2O)对 SCID 小鼠进行全身氘代处理,可抑制人胰腺导管腺癌的原位生物发光模型中的肿瘤生长。
Mol Carcinog. 2023 May;62(5):598-612. doi: 10.1002/mc.23509. Epub 2023 Feb 2.
2
Brachytherapy via a depot of biopolymer-bound I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours.生物聚合物结合碘 125 的近距离放疗与纳米颗粒紫杉醇协同作用,可治疗耐药性胰腺肿瘤。
Nat Biomed Eng. 2022 Oct;6(10):1148-1166. doi: 10.1038/s41551-022-00949-4. Epub 2022 Oct 19.
3
In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation.体内生物发光断层成像中心质量引导适形照射。
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):612-620. doi: 10.1016/j.ijrobp.2019.11.003. Epub 2019 Nov 15.
4
Mouse pancreatic islet macrophages use locally released ATP to monitor beta cell activity.小鼠胰腺胰岛巨噬细胞利用局部释放的 ATP 来监测β细胞活性。
Diabetologia. 2018 Jan;61(1):182-192. doi: 10.1007/s00125-017-4416-y. Epub 2017 Sep 7.
5
Dosimetry in Micro-computed Tomography: a Review of the Measurement Methods, Impacts, and Characterization of the Quantum GX Imaging System.微计算机断层扫描中的剂量学:量子GX成像系统的测量方法、影响及特性综述
Mol Imaging Biol. 2017 Aug;19(4):499-511. doi: 10.1007/s11307-016-1026-x.
6
Evaluation of On- and Off-Line Bioluminescence Tomography System for Focal Irradiation Guidance.用于聚焦照射引导的在线和离线生物发光断层扫描系统评估
Radiat Res. 2016 Dec;186(6):592-601. doi: 10.1667/RR14423.1. Epub 2016 Nov 21.
7
Bioluminescence Tomography-Guided Radiation Therapy for Preclinical Research.用于临床前研究的生物发光断层扫描引导放射治疗
Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1144-53. doi: 10.1016/j.ijrobp.2015.11.039. Epub 2015 Dec 14.
8
ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.ATR/MAPKAPK2 介导的 ATDC/TRIM29 磷酸化在胰腺癌细胞的放射抵抗中起作用。
Cancer Res. 2014 Mar 15;74(6):1778-88. doi: 10.1158/0008-5472.CAN-13-2289. Epub 2014 Jan 27.
9
Lessons learned from radiation oncology clinical trials.从放射肿瘤学临床试验中吸取的经验教训。
Clin Cancer Res. 2013 Nov 15;19(22):6089-100. doi: 10.1158/1078-0432.CCR-13-1116. Epub 2013 Sep 16.
10
Preclinical models in radiation oncology.放射肿瘤学的临床前模型。
Radiat Oncol. 2012 Dec 27;7:223. doi: 10.1186/1748-717X-7-223.

本文引用的文献

1
Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model.实时高分辨率复合成像可在原位小鼠胰腺癌模型中进行经皮启动和监测。
Pancreas. 2008 Mar;36(2):146-52. doi: 10.1097/MPA.0b013e3181586cd9.
2
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
3
In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells.通过荧光素酶基因标记的间充质干细胞监测异位骨形成的体内生物发光成像研究。
J Orthop Res. 2008 Jul;26(7):901-9. doi: 10.1002/jor.20582.
4
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.使用原位异种移植模型评估表皮生长因子受体扩增对胶质母细胞瘤放疗反应的影响。
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2264-71. doi: 10.1158/1078-0432.CCR-05-2510.
5
Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression.人胶质瘤细胞的原位生长在定量和定性方面影响辐射诱导的基因表达变化。
Cancer Res. 2005 Nov 15;65(22):10389-93. doi: 10.1158/0008-5472.CAN-05-1904.
6
Imaging of luciferase and GFP-transfected human tumours in nude mice.裸鼠体内荧光素酶和绿色荧光蛋白转染的人肿瘤成像。
Luminescence. 2003 Jul-Aug;18(4):218-23. doi: 10.1002/bio.729.
7
The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta.肿瘤微环境:TGFβ肿瘤抑制和促进作用的潜在仲裁者
Differentiation. 2002 Dec;70(9-10):574-82. doi: 10.1046/j.1432-0436.2002.700910.x.
8
Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases.荧光素酶标记的人前列腺肿瘤和转移灶的联合无创成像与发光定量分析。
Lab Invest. 2002 Nov;82(11):1563-71. doi: 10.1097/01.lab.0000036877.36379.1f.
9
Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model.在原位小鼠前列腺癌模型中,具有复制能力的腺病毒介导的双自杀基因疗法联合放射治疗的疗效和毒性。
Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):873-85. doi: 10.1016/s0360-3016(02)03005-5.
10
Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.胰腺癌原位模型中原发性肿瘤生长和多个转移事件的实时光学成像。
Cancer Res. 2002 Mar 1;62(5):1534-40.